Articles

‘My retirement is completely in bitcoin’: Why don’t more people do what I do?

“‘I also borrow against bitcoin. What’s the catch?”

Meta is undergoing a shakeup. Will it help the company make more money off AI?

Meta’s chief revenue officer is leaving at a time when Wall Street has become more concerned about the return on AI investments.

Bitcoin ETF posts record outflow amid crypto bear market

The biggest bitcoin ETF fund is in a slump after investors bailed from the fund like never before.

Living to 100 is becoming a reality. Can you afford it?

The odds of becoming a centenarian are growing — how to plan for the possibility

Why Apple’s stock is beating the market even as tech stocks sell off

Apple has been seen as an AI loser. That means it’s stock hasn’t gotten caught up in the heavy selling pressure on AI stocks.

Nio’s stock suffers longest losing streak in nearly two years as earnings pressure builds

Nio reports third-quarter results next week. After that the company will be in the hot seat, as it’s set out to reach profitability by the fourth quarter.

President Trump is threatening to relocate some 2026 FIFA World Cup games. Should fans be worried?

“The governors and mayors are going to have to behave,” Trump said about certain Democratic leaders.

Two more ‘Magnificent Seven’ stocks are now in correction territory as the AI trade unwinds

With 10%-plus drops off their recent closing highs, Amazon and Nvidia shares have joined Tesla shares in correction territory. Meta’s stock is already in a bear market.

Nvidia earnings have become crucial to the stock market — and this time even more so

AI stocks are under pressure as investors await a big rate-cut decision. Nvidia will look to steady the ship when it reports results on Wednesday afternoon.

Bitcoin has been sliding. These charts show why — and what might happen next.

Liquidity has been draining out of the financial system, putting pressure on speculative assets like cryptocurrencies.

The S&P 500 and Dow extend their losing streaks to a fourth day. Are stocks headed for a full 10% correction?

Over 320 of the S&P 500’s components ended trading at least 10% below their 52-week highs on Tuesday, while the index was off 4% from its recent high

Why biotech and drug stocks are on the mend even though the rest of the market is hurting

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded away.
1 2 3 4 5 2,438